About Paradigm
Paradigm Health is transforming clinical trial execution through an AI-native platform that integrates directly with healthcare provider systems and workflows. The company addresses critical inefficiencies in drug development, where 50% of trials fail to meet enrollment targets and the average drug takes 12+ years to reach market at a cost exceeding $2.6 billion. Paradigm Health's end-to-end solution serves both trial sponsors and research sites, offering protocol optimization, feasibility analysis, site selection, patient identification, enrollment acceleration, and automated data capture. The platform leverages real-time EHR data and AI-powered screening to identify eligible patients within provider workflows, supported by experienced clinical research coordinators. For sponsors, Paradigm Health delivers faster study startup, stronger enrollment performance, and higher-quality data through eSource-powered sites and automated data workflows. For providers, the platform simplifies research conduct by reducing administrative burden and enabling seamless integration with existing care delivery. The company operates a network of over 100 research sites across the United States, Japan, and Israel, partnering with community healthcare providers and academic medical centers. Paradigm Health supports Phase I-IV clinical trials, including interventional, observational, and pragmatic studies, with particular strength in oncology and rare disease research. The company's approach has demonstrated measurable outcomes, including 6.5x faster enrollment in multiple myeloma trials and 45% increased enrollment at partner sites like Highlands Oncology.
Mission & Story
Mission
Paradigm Health believes in a world where every patient has access to the latest care through clinical trials.
Clinical Focus
Medical conditions and clinical areas addressed by Paradigm.
Who It Serves
Milestones & Awards
Recent Milestones
Network expansion to 100+ research sites across US, Japan, and Israel; partnerships with 75% of top 20 biopharma sponsors; demonstrated 6.5x enrollment acceleration in multiple myeloma trials
Key Partnerships
Social & Media
Latest Updates
On-Demand Webinar | Lessons Learned in Embedding Pragmatic Studies in Routine Clinical Care
Inside the FDA's Real-Time Clinical Trials Initiative: Key Takeaways for Sponsors and Providers
Paradigm Health Submits Response to FDA's Real-Time Clinical Trials Initiative RFI, Informed by Biopharma Sponsors and Providers
Paradigm in the News
All News →
Lab-Grown Blood Vessels Show Promise in Reversing Heart Disease Damage
Can Rheumatoid Arthritis Be Stopped Before It Starts? Landmark Trial Shows 60% Prevention Success
AI-Powered Synthetic Heart Could End Animal Testing in Cardiac Device Development
Why the FDA Is Betting on Biology-Driven AI to Fix Drug Development's $2 Billion Failure Problem
Company Details
- Headquarters
- Columbus, OH, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.